Browse drugs

…and upper gastrointestinal cancers were similar between groups. Orlistat was associated with a higher risk of kidney stones (5.9% vs 4.5…

… history of receiving novel antidiabetic medications (SGLT2i or GLP-1RA). Sensitivity analyses were also conducted in participants with…

…pre-eclampsia, and three patients had diabetes mellitus (one on insulin). Nine mothers were clinically overweight, and five had a BMI o…

…, France and Italy). Patients taking oral antidiabetic drugs or insulin were classified as having DM, regardless of subtype. Given the …

…2.67, 71 subjects were on oral hypoglycemic medications such as metformin, sulfonylureas, pioglitazone, DPP-4 inhibitors, and SGLT2 inhib…

… 6-month observation period using the monitoring method choice. Insulin and dietary adjustments were undertaken as per local care stand…

…has been shown to influence the effectiveness of treatment with niacin in reducing liver fat in people with dyslipidemia.20 Despite be…

…n T1D pathogenesis, including therapeutic B cell depletion with rituximab, which preserved beta-cell function for 1 year,38 and variation…

…etes was 10 years, and 18% of the study sample was treated with insulin ( table 2). Online supplemental table S4 describes the characte…

…with low baseline glucose levels. Inhaled beta-agonists such as salbutamol provide an effective and synergistic potassium-lowering effect …

… among the GLP-1RA group compared with the sulfonylureas group. GLP-1RA=glucagon-like peptide-1 receptor agonistsDiscussionIn this nati…

…ood glucose concentrations, macronutrient intake nor receipt of insulin was consistently related to ketone or lactate concentrations.Co…